Refreshed and Refocused for 2025: Insights from Life Sciences Commercial Leaders

In our latest pulse check survey, we asked life sciences commercial leaders in specialty and niche markets about their top priorities, data and technology investments, and resource allocation strategies for 2025.

• AI is moving beyond pilots – 85% of teams are implementing GenAI across multiple functions, shifting from experimentation to operationalization.
• Leaders are rethinking efficiency – With 76% expected to do more with fewer resources, AI is emerging as a strategic growth driver, not just an automation tool.
• Data foundations are in focus – Gaps in data management and patient journey mapping are becoming urgent priorities.

This briefing distills key trends, investment areas, and success factors from organizations driving real value with AI, analytics, and technology.

Explore survey findings and best practices: